From Our Editors · Special Report
Xcelerating Life Sciences San Francisco: Special Report
The AI, Big Data, and R&D Boom
Learn what’s fueling San Francisco’s boom in AI, big data, and R&D, explore promising investment and partnership opportunities, and align the latest trends and technologies with your business by downloading our special report complementing Xconomy’s recent Xcelerating Life Sciences event.
The Xconomy special report includes:
- Implementing the “Tech” in Biotech
- Data Quantity, Complexity Drives AI Adoption in Drug Discovery & Testing
- The Fine Balance Between Biology and Tech in the San Francisco Startup Scene
- Code for Cures: Life Sciences Thrives on San Francisco’s Software Heritage
Artificial intelligence, including machine and deep learning, are revolutionizing the drug discovery and development process – bringing with it unprecedented levels of speed and efficiency. Meanwhile, San Francisco’s unparalleled tech ecosystem provides Bay Area biotechs proximity to myriad opportunities for AI integration. Join us to explore the latest technology and business trends in this burgeoning sector through the lens of some of San Francisco’s top life science leaders and rising stars, and learn how AI is impacting investment and partnerships.